Key clinical point: In a new trial analysis, an implantable alert device relative to a sham identified silent MIs and avoided false positive ER visits.
Major finding: False-positive ER visits fell from 0.678 when device was off to 0.164/year (P less than .001) when device was activated.
Data source: ALERTS, a multicenter, randomized controlled trial
Disclosures: Dr. Gibson has financial relationships with many companies, including Angel Medical Systems, the sponsor of this trial.
REPORTING FROM CRT 2019
This Week's Must Reads
Must Reads in Cardiology
Consumption of SSBs & Risk of Mortality, Circulation; ePub 2019 Mar 18; Malik, et al
Dietary Cholesterol or Egg Consumption & CVD, JAMA; 2019 Mar 19; Zhong, Van Horn, et al